基于定量系统药理学探索临床实践中相关的抗淀粉样蛋白治疗难题

Addressing practical challenges in clinical practice after the recent approvals of amyloid antibodies in Alzheimer’s disease (AD) will benefit more patients. However, generating these answers using clinical trials or real-world evidence is not practical, nor feasible.